Supreme Court To Consider Federal Pre-Emption In Wyeth V. Levine Next Week (Medical News Today)
The U.S. Supreme Court next week will begin hearing the case of Wyeth v. Levine, which centers on the question of whether FDA approval of a drug warning label pre-empts product safety suits brought in state courts, the Wall Street Journal reports (Mundy/Wang, Wall Street Journal, 10/27).

FDA should lift stevia import alert, says ABC (Nutraingredients.com)
In the upcoming issue of HerbalGram , ABC s publication, Mark Blumenthal, ABC s founder and executive director, calls FDA s 1991 Import Alert on stevia for use as a food additive "unreasonable and illogical" given the "current scientific and medical information supporting the safety of stevia when consumed in relatively small amounts in foods to give them a sweet taste."

Marck Bioscience eyes US FDA approval, acquisition in US (PharmaBiz)
In an effort to expand its reach in the regulated markets of US and Europe, the Ahmedabad-based Marck Biosciences Ltd, a noted manufacturer and marketer of sterile liquid parenterals, is likely to file for US Food and Drug Administration (FDA) approval for its facility at Kheda in the next six months.